TR200100066T2 - Göz enfeksiyonlarının tedavisi için oksazolidinonlar. - Google Patents

Göz enfeksiyonlarının tedavisi için oksazolidinonlar.

Info

Publication number
TR200100066T2
TR200100066T2 TR2001/00066T TR200100066T TR200100066T2 TR 200100066 T2 TR200100066 T2 TR 200100066T2 TR 2001/00066 T TR2001/00066 T TR 2001/00066T TR 200100066 T TR200100066 T TR 200100066T TR 200100066 T2 TR200100066 T2 TR 200100066T2
Authority
TR
Turkey
Prior art keywords
treatment
oxazolidinones
eye infections
treating
effective amount
Prior art date
Application number
TR2001/00066T
Other languages
English (en)
Inventor
Cochran Robert
W. Ford Charles
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of TR200100066T2 publication Critical patent/TR200100066T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu bulus, tedaviye ihtiyaci olan yararli bir sicak kanli memelide, bir göz enfeksiyonunu tedavi etmeye mahsus bir yöntemle ilgili olup, bu yöntem, bir oksazolidinon bilesiginin oftalmik açidan etkili bir miktarinin lokal olarak tatbik edilmesini içerir.
TR2001/00066T 1998-07-14 1999-07-07 Göz enfeksiyonlarının tedavisi için oksazolidinonlar. TR200100066T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9276598P 1998-07-14 1998-07-14

Publications (1)

Publication Number Publication Date
TR200100066T2 true TR200100066T2 (tr) 2001-05-21

Family

ID=22235050

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00066T TR200100066T2 (tr) 1998-07-14 1999-07-07 Göz enfeksiyonlarının tedavisi için oksazolidinonlar.

Country Status (27)

Country Link
US (2) US6337329B1 (tr)
EP (1) EP1096934B1 (tr)
JP (1) JP2002520359A (tr)
KR (1) KR20010079530A (tr)
CN (1) CN1305374A (tr)
AT (1) ATE304886T1 (tr)
AU (1) AU740781B2 (tr)
BG (1) BG64666B1 (tr)
BR (1) BR9912004A (tr)
CA (1) CA2334811A1 (tr)
DE (1) DE69927380T2 (tr)
DK (1) DK1096934T3 (tr)
EA (1) EA003274B1 (tr)
EE (1) EE200100026A (tr)
ES (1) ES2249020T3 (tr)
HU (1) HUP0102836A3 (tr)
ID (1) ID27276A (tr)
IL (1) IL140769A0 (tr)
NO (1) NO20010202L (tr)
NZ (1) NZ509375A (tr)
PL (1) PL345544A1 (tr)
PT (1) PT1096934E (tr)
SG (1) SG125079A1 (tr)
SK (1) SK20332000A3 (tr)
TR (1) TR200100066T2 (tr)
WO (1) WO2000003710A1 (tr)
ZA (1) ZA200100038B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
KR20020063851A (ko) * 1999-09-13 2002-08-05 인사이트 비젼 인코포레이티드 안구 감염 예방용 국소 치료제
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6562820B2 (en) * 2000-07-05 2003-05-13 Pharmacia & Upjohn Company Method for treatment and prevention of mastitis
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
US20030069235A1 (en) * 2001-09-14 2003-04-10 J. Greg Slatter Treatment for ocular infections
BR0307898A (pt) * 2002-02-22 2004-12-07 Pharmacia Corp Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
CN101766628B (zh) * 2010-01-20 2012-07-04 广东宏盈科技有限公司 一种眼科外用抗细菌感染药物
JP6419701B2 (ja) * 2012-09-13 2018-11-07 スターファーマ・ピーティーワイ・リミテッド 眼の感染症の治療または予防方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CA2174107C (en) * 1993-11-22 2005-04-12 Steven J. Brickner Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
EP0951295B1 (en) 1996-05-31 2010-06-09 The Scripps Research Institute Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis

Also Published As

Publication number Publication date
HUP0102836A2 (hu) 2002-05-29
EA003274B1 (ru) 2003-04-24
HUP0102836A3 (en) 2003-12-29
BR9912004A (pt) 2001-04-10
WO2000003710A1 (en) 2000-01-27
PT1096934E (pt) 2005-11-30
ES2249020T3 (es) 2006-03-16
SK20332000A3 (sk) 2001-05-10
ATE304886T1 (de) 2005-10-15
JP2002520359A (ja) 2002-07-09
DE69927380D1 (de) 2005-10-27
AU740781B2 (en) 2001-11-15
KR20010079530A (ko) 2001-08-22
EA200100133A1 (ru) 2001-06-25
BG105142A (en) 2001-10-31
EP1096934A1 (en) 2001-05-09
NZ509375A (en) 2003-11-28
PL345544A1 (en) 2001-12-17
DE69927380T2 (de) 2006-07-06
US6740652B2 (en) 2004-05-25
BG64666B1 (bg) 2005-11-30
NO20010202D0 (no) 2001-01-12
NO20010202L (no) 2001-01-12
ID27276A (id) 2001-03-22
IL140769A0 (en) 2002-02-10
CA2334811A1 (en) 2000-01-27
EE200100026A (et) 2002-06-17
ZA200100038B (en) 2002-01-02
CN1305374A (zh) 2001-07-25
DK1096934T3 (da) 2005-11-28
EP1096934B1 (en) 2005-09-21
US6337329B1 (en) 2002-01-08
SG125079A1 (en) 2006-09-29
AU4953099A (en) 2000-02-07
US20020065280A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
TR200100066T2 (tr) Göz enfeksiyonlarının tedavisi için oksazolidinonlar.
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
CY1108765T1 (el) ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2
MXPA02007099A (es) Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina.
PL353750A1 (en) Dosages for treatment with anti-erbb2 antibodies
DK0665013T3 (da) Behandling af hyperproliferative karsygdomme
TR200000059T2 (tr) Piridin türevleri
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
TR200003280T2 (tr) Katarakt çıkarma için cerrahi prosedürlerin kolaylaştırılması için bir vital boyanın kullanımı.
FR2831818B1 (fr) Composition oxydante pour le traitement des fibres keratiniques comprenant une silicone aminee particuliere
NO883306L (no) Farmasoeytisk aktive konjugater med forbedret bindingsspesifisitet for kroppsvev.
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
TR200102864T2 (tr) N”rolojik ya da n”ropsikiyatrik bozukluklarìn tedavisi i‡in y”ntem
FR2831817B1 (fr) Composition reductrice pour le traitement des fibres keratiniques comprenant une silicone aminee particuliere
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
DE60142899D1 (de) Verbindungen für den transfer von oligonukleotiden
DE69531459D1 (de) Elatase-inhibitoren
FR2831809B1 (fr) Composition oxydante pour le traitement des fibres keratiniques comprenant une silicone aminee particuliere
EA200100010A1 (ru) Местное применение оксазолидинонов для трансдермальной доставки
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung